Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of midazolam on immediate cognitive function in elderly hepatocellular carcinoma patients undergoing radiofrequency ablation
TCTR20180913004Active, not recruiting
- Sponsor
- Faculty of Medicine
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of midazolam in hepatocellular carcinoma (HCC), sponsored by Faculty of Medicine. Primary endpoint: Immediate cognitive function after procedure. Started Mar 2018; status: active, not recruiting.
02
Drugs
midazolam
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on TCTR20180913004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180913004.